F10 and atrial fibrillation: Although factor Xa inhibitors have proved their safety and efficacy against VKAs in RCTs, patients with AF and other comorbidities comprising older age, frailty, low body weight or obesity, chronic kidney disease, severe anemia, and chronic liver failure are often underrepresented in the RCTs.